International Isotopes Inc. (INIS)

Market Cap	22.34M
Revenue (ttm)	12.27M
Net Income (ttm)	-1.93M
Shares Out	520.08M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,895
Open	0.0386
Previous Close	0.0420
Day's Range	0.0386 - 0.0430
52-Week Range	0.0200 - 0.1000
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 3, 2023

About INIS

International Isotopes Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, and radiopharmaceutical and radiochemical contract manufacturing services in the United States and internationally. It operates through four segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products. The Nuclear Medicine Standards segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positionin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Aug 14, 1997
• Employees: 39
• Stock Exchange: OTCMKTS
• Ticker Symbol: INIS

Financial Performance

In 2023, INIS's revenue was $12.27 million, an increase of 9.71% compared to the previous year's $11.18 million. Losses were -$869,016, 179.7% more than in 2022.